{"transactions":[{"id":4064,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":2663,"kind":"person","name":"Plump Andrew Stewart","position":1,"cik":"0001977689","reported_name":"Plump Andrew Stewart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"American Depositary Shares","published_at":"2026-09-04T01:49:19.000Z","date":"2026-09-02","kind":"sale","planned":true,"acquired":false,"shares":116191,"price":18.49,"value":2148371.59,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported herein were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026."}],"balance_after":145465,"source":{"system":"sec-edgar","filing":"0001395064-26-000335","document":"wk-form4_1788486556.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1977689/000139506426000335/wk-form4_1788486556.xml","form_type":"4"}},{"id":678593,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":2663,"kind":"person","name":"Plump Andrew Stewart","position":1,"cik":"0001977689","reported_name":"Plump Andrew Stewart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"American Depositary Shares","published_at":"2026-08-21T20:30:13.000Z","date":"2026-08-19","kind":"sale","planned":true,"acquired":false,"shares":19651,"price":18.49,"value":363346.99,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported herein were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026."}],"balance_after":261656,"source":{"system":"sec-edgar","filing":"0001493152-26-039693","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226039693/ownership.xml","form_type":"4"}},{"id":689039,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":2663,"kind":"person","name":"Plump Andrew Stewart","position":1,"cik":"0001977689","reported_name":"Plump Andrew Stewart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"American Depositary Shares","published_at":"2026-08-13T01:50:30.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":165393,"price":17.1,"value":2828220.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":766569,"source":{"system":"sec-edgar","filing":"0001493152-26-037507","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226037507/ownership.xml","form_type":"4"}},{"id":714583,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":2663,"kind":"person","name":"Plump Andrew Stewart","position":1,"cik":"0001977689","reported_name":"Plump Andrew Stewart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"American Depositary Shares","published_at":"2026-07-06T22:01:15.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":125390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027."}],"balance_after":931962,"source":{"system":"sec-edgar","filing":"0001395064-26-000244","document":"wk-form4_1783375271.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000244/wk-form4_1783375271.xml","form_type":"4"}},{"id":798713,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":2663,"kind":"person","name":"Plump Andrew Stewart","position":1,"cik":"0001977689","reported_name":"Plump Andrew Stewart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"American Depositary Shares","published_at":"2026-04-28T10:07:30.000Z","date":"2026-04-27","kind":"grant","planned":false,"acquired":true,"shares":212470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of American Depositary Shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones.  On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 464.432 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one American Depositary Share.  The RSUs vest on the following schedule: July 1, 2026 (329,478 shares), July 1, 2027 (91,580 shares) and July 1, 2028 (43,374 shares)."}],"balance_after":806572,"source":{"system":"sec-edgar","filing":"0001395064-26-000136","document":"wk-form4_1777370848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000136/wk-form4_1777370848.xml","form_type":"4"}}]}